Mutual dependence of MDM2 and MDMX in their functional inactivation of p53

Jijie Gu, Hidehiko Kawai, Linghu Nie, Hiroyuki Kitao, Dmitri Wiederschain, Aart G. Jochemsen, John Parant, Guillermina Lozano, Zhi Min Yuan

研究成果: ジャーナルへの寄稿記事

190 引用 (Scopus)

抄録

MDMX, an MDM2-related protein, has emerged as yet another essential negative regulator of p53 tumor suppressor, since loss of MDMX expression results in p53-dependent embryonic lethality in mice. However, it remains unknown why neither homologue can compensate for the loss of the other. In addition, results of biochemical studies have suggested that MDMX inhibits MDM2-mediated p53 degradation, thus contradicting its role as defined in gene knockout experiments. Using cells deficient in either MDM2 or MDMX, we demonstrated that these two p53 inhibitors are in fact functionally dependent on each other. In the absence of MDMX, MDM2 is largely ineffective in down-regulating p53 because of its extremely short half-life. MDIMX renders MDM2 protein sufficiently stable to function at its full potential for p53 degradation. On the other hand, MDMX, which is a cytoplasmic protein, depends on MDM2 to redistribute into the nucleus and be able to inactivate p53. We also showed that MDMX, when exceedingly overexpressed, inhibits MDM2-mediated p53 degradation by competing with MDM2 for p53 binding. Our findings therefore provide a molecular basis for the nonoverlapping activities of these two p53 inhibitors previously revealed in genetic studies.

元の言語英語
ページ(範囲)19251-19254
ページ数4
ジャーナルJournal of Biological Chemistry
277
発行部数22
DOI
出版物ステータス出版済み - 5 31 2002
外部発表Yes

Fingerprint

Degradation
Gene Knockout Techniques
Proteins
Half-Life
Tumors
Genes
Neoplasms
Experiments

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

これを引用

Gu, J., Kawai, H., Nie, L., Kitao, H., Wiederschain, D., Jochemsen, A. G., ... Yuan, Z. M. (2002). Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. Journal of Biological Chemistry, 277(22), 19251-19254. https://doi.org/10.1074/jbc.C200150200

Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. / Gu, Jijie; Kawai, Hidehiko; Nie, Linghu; Kitao, Hiroyuki; Wiederschain, Dmitri; Jochemsen, Aart G.; Parant, John; Lozano, Guillermina; Yuan, Zhi Min.

:: Journal of Biological Chemistry, 巻 277, 番号 22, 31.05.2002, p. 19251-19254.

研究成果: ジャーナルへの寄稿記事

Gu, J, Kawai, H, Nie, L, Kitao, H, Wiederschain, D, Jochemsen, AG, Parant, J, Lozano, G & Yuan, ZM 2002, 'Mutual dependence of MDM2 and MDMX in their functional inactivation of p53', Journal of Biological Chemistry, 巻. 277, 番号 22, pp. 19251-19254. https://doi.org/10.1074/jbc.C200150200
Gu, Jijie ; Kawai, Hidehiko ; Nie, Linghu ; Kitao, Hiroyuki ; Wiederschain, Dmitri ; Jochemsen, Aart G. ; Parant, John ; Lozano, Guillermina ; Yuan, Zhi Min. / Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. :: Journal of Biological Chemistry. 2002 ; 巻 277, 番号 22. pp. 19251-19254.
@article{5eb6ad067c8b48419f182a17a228bb78,
title = "Mutual dependence of MDM2 and MDMX in their functional inactivation of p53",
abstract = "MDMX, an MDM2-related protein, has emerged as yet another essential negative regulator of p53 tumor suppressor, since loss of MDMX expression results in p53-dependent embryonic lethality in mice. However, it remains unknown why neither homologue can compensate for the loss of the other. In addition, results of biochemical studies have suggested that MDMX inhibits MDM2-mediated p53 degradation, thus contradicting its role as defined in gene knockout experiments. Using cells deficient in either MDM2 or MDMX, we demonstrated that these two p53 inhibitors are in fact functionally dependent on each other. In the absence of MDMX, MDM2 is largely ineffective in down-regulating p53 because of its extremely short half-life. MDIMX renders MDM2 protein sufficiently stable to function at its full potential for p53 degradation. On the other hand, MDMX, which is a cytoplasmic protein, depends on MDM2 to redistribute into the nucleus and be able to inactivate p53. We also showed that MDMX, when exceedingly overexpressed, inhibits MDM2-mediated p53 degradation by competing with MDM2 for p53 binding. Our findings therefore provide a molecular basis for the nonoverlapping activities of these two p53 inhibitors previously revealed in genetic studies.",
author = "Jijie Gu and Hidehiko Kawai and Linghu Nie and Hiroyuki Kitao and Dmitri Wiederschain and Jochemsen, {Aart G.} and John Parant and Guillermina Lozano and Yuan, {Zhi Min}",
year = "2002",
month = "5",
day = "31",
doi = "10.1074/jbc.C200150200",
language = "English",
volume = "277",
pages = "19251--19254",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "22",

}

TY - JOUR

T1 - Mutual dependence of MDM2 and MDMX in their functional inactivation of p53

AU - Gu, Jijie

AU - Kawai, Hidehiko

AU - Nie, Linghu

AU - Kitao, Hiroyuki

AU - Wiederschain, Dmitri

AU - Jochemsen, Aart G.

AU - Parant, John

AU - Lozano, Guillermina

AU - Yuan, Zhi Min

PY - 2002/5/31

Y1 - 2002/5/31

N2 - MDMX, an MDM2-related protein, has emerged as yet another essential negative regulator of p53 tumor suppressor, since loss of MDMX expression results in p53-dependent embryonic lethality in mice. However, it remains unknown why neither homologue can compensate for the loss of the other. In addition, results of biochemical studies have suggested that MDMX inhibits MDM2-mediated p53 degradation, thus contradicting its role as defined in gene knockout experiments. Using cells deficient in either MDM2 or MDMX, we demonstrated that these two p53 inhibitors are in fact functionally dependent on each other. In the absence of MDMX, MDM2 is largely ineffective in down-regulating p53 because of its extremely short half-life. MDIMX renders MDM2 protein sufficiently stable to function at its full potential for p53 degradation. On the other hand, MDMX, which is a cytoplasmic protein, depends on MDM2 to redistribute into the nucleus and be able to inactivate p53. We also showed that MDMX, when exceedingly overexpressed, inhibits MDM2-mediated p53 degradation by competing with MDM2 for p53 binding. Our findings therefore provide a molecular basis for the nonoverlapping activities of these two p53 inhibitors previously revealed in genetic studies.

AB - MDMX, an MDM2-related protein, has emerged as yet another essential negative regulator of p53 tumor suppressor, since loss of MDMX expression results in p53-dependent embryonic lethality in mice. However, it remains unknown why neither homologue can compensate for the loss of the other. In addition, results of biochemical studies have suggested that MDMX inhibits MDM2-mediated p53 degradation, thus contradicting its role as defined in gene knockout experiments. Using cells deficient in either MDM2 or MDMX, we demonstrated that these two p53 inhibitors are in fact functionally dependent on each other. In the absence of MDMX, MDM2 is largely ineffective in down-regulating p53 because of its extremely short half-life. MDIMX renders MDM2 protein sufficiently stable to function at its full potential for p53 degradation. On the other hand, MDMX, which is a cytoplasmic protein, depends on MDM2 to redistribute into the nucleus and be able to inactivate p53. We also showed that MDMX, when exceedingly overexpressed, inhibits MDM2-mediated p53 degradation by competing with MDM2 for p53 binding. Our findings therefore provide a molecular basis for the nonoverlapping activities of these two p53 inhibitors previously revealed in genetic studies.

UR - http://www.scopus.com/inward/record.url?scp=0037205454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037205454&partnerID=8YFLogxK

U2 - 10.1074/jbc.C200150200

DO - 10.1074/jbc.C200150200

M3 - Article

C2 - 11953423

AN - SCOPUS:0037205454

VL - 277

SP - 19251

EP - 19254

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 22

ER -